language_icon
EN
HI

Lincoln Pharmaceuticals Share price

LINCOLN

678.9

34.70 (5.39%)
NSE
BSE
Last updated on 18 May, 2026 | 15:55 IST
Today's High

694.00

Today's Low

621.10

52 Week Low

440.00

52 Week High

733.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Lincoln Pharmaceuticals Chart

Lincoln Pharmaceuticals Share Key Metrics

Volume
1.41 L
Market Cap
1359.82 CR
LTQ@LTP
5@678.90
ATP
661.25
Var Margin
20.37 %
Circuit Range
515.4-773
Delivery %
57.8 %
Value
9.33 CR
ASM/GSM
No
Market Lot
1

Summary

18 May, 2026 | 15:55 को, Lincoln Pharmaceuticals का शेयर प्राइस आज ₹678.9 पर है, जो दिन के लिए 34.70% की 5.39 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹621.10 और ₹694.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹440.00 से ₹733.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Lincoln Pharmaceuticals ने 141117 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹20029728 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹66125 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 5,67890 रही। यह स्टॉक ₹515.4-773 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹9.33 CR है। दिन के लिए डिलीवरी परसेंटेज 57.8% रही। इसके अतिरिक्त, Lincoln Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Lincoln Pharmaceuticals Fundamentals

View More
P/E Ratio

14.71

P/B Ratio

1.74

Div. Yield

0.28

Sector P/E

71.32

Sector P/B

3.45

Sec. Div. Yield

0.56

Lincoln Pharmaceuticals Resistance and Support

Pivot 650.3

Resistance

First Resistance

659.35

Second Resistance

674.5

Third Resistance

683.55

Support

First Support

635.15

Second Support

626.1

Third Support

610.95

Lincoln Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

49.78%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

5.16%

Domestic Institutional Investors

0%

Retail

45.06%

Others

0%

Total Promoters
MAR '24
49.53%
JUN '24
49.78%
SEP '24
49.78%
DEC '24
49.78%

Lincoln Pharmaceuticals Corporate Actions

DateAgenda
2026-02-12Quarterly Results

Lincoln Pharmaceuticals News

Lincoln Pharmaceuticals Ltd - 531633 - Corporate Action-Board to consider Dividend

Lincoln board will meet on May 28, 2026, to consider a dividend recommendation for equity shares. The meeting also includes approval of audited financial results for the quarter and year ended March 31, 2026.
May 18 2026 14:05:00

Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Consideration Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026.

Lincoln Pharma board meeting scheduled for May 28, 2026, to approve audited financial results for Q4 and year ended March 31, 2026, and to recommend a dividend for shareholders.
May 18 2026 14:05:00

About Lincoln Pharmaceuticals AboutThe

NSE : 11596  
BSE : 531633  
ISIN : INE405C01035  

The Company was incorporated as a public limited company by converting partnership concern M/s. Lincoln Pharmaceuticals under Part IX of the Companies Act 1956. M/s.Lincoln Pharmaceuticals was established as a partnership firm on 18th January 1979 with Mr. Rajni G. Patel Mr. Hasmukhbhai I.Patel Mrs. Hansaben A.Patel Mrs. Jivtiben C.Patel Mrs.Jiviben T.Patel and Mrs. Lilaben T. Patel as partners with its main object of manufacturing pharmaceutical formulations. The business was started in Naroda G.I.D.C estate. Further on 9.12.81 Mr.Mihir V. Patel Mr.Maheshbhai M.Patel Mr.Yogeshkumar I. Patel and Mrs.Madhuben V.Patel were admitted as Partners. The firm was carrying on its business by getting its products manufactured on Loan and Licence Basis from 1979 to 1982.All the partners decided and agreed vide resolution dated 30.10.94 that all members of Co-partnership should register the said firm as public limited company for sake of smooth working better and effective management and improvement and advancement of business. It was also decided as per the said resolution that such company should carry Out and continue the existing business of the firm. As a result anthe incorporation of the Company on 20th January 1995 all the properties of the firm (movable & immovable) and all the liabilities of the firm 55 an the closing of the business of the day proceeding the date of incorporation of the Company vested in the Company. Since date of incorporation of the Company i.e 20th January 1995 all the assets and liabilities aforesaid as on 19th January 1995 vested in the Company. Company is carrying on running business of erstwhile M/s. Lincoln Pharmaceuticals having its formulations production facilities at Naroda GIDC Ahmedabad Gujarat of manufacturing tablets capsules liquid and powder syrups and ointments. Company is alsogetting its products manufactured on "Loan and License" basis from other manufacturers to meet the demand of small volume parenterals.The Company has now decided to establish modern formulations manufacturing plant at Village: Khatraj. Tal:Kalol Olaf. Mehsana in Gujarat to manufacture small volume parenterals like Dry powder injectables liquid vial liquid ampoules and eye drops and expand itsproduction capacities of manufacturing tablets capsules liquid/powder syrups and ointment and also to establish fully equipped laboratory to undertake in house testing of its products for better quality control and give thrust on Research and Development. Company has already acquired N.A land Adm: 8833 Sq. Mtrs. and is in the process of acquiring further land adm. aprox.11170 Sq.Mtrs. Company has givenadvance for booking cement and steel and are preparing to commence construction of factory building at new site. Company has identified all plant and machineries and has also given advance to major plant & machinery suppliers far those machineries which has longer delivery period so as to implement the project an time. The company has existing manufacturing facilities at Naroda and if is alreadyselling its products all over India and is having thrust in the markets of Gujarat Rajasthan Andhra Pradesh Bihar and Jammu.

Read More

Lincoln Pharmaceuticals Management

NamePosition
Trusha ShahCompany Secretary & Compliance Officer
Kishor M ShahChairman
View More

Lincoln Pharmaceuticals FAQs

Lincoln Pharmaceuticals शेयर का खरीद मूल्य 678.9 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Lincoln Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Lincoln Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 14.71 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Lincoln Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 1.74 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Lincoln Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.45 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Lincoln Pharmaceuticals का मार्केट कैप 1359.82 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Lincoln Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 733.00 और 440.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost